Drug Patent Profile
Neratinib - Puma Biotechnology
At a glance
- Drug Originator Wyeth
- Drug Licenced by Bixink Therapeutics; Knight Therapeutics; Medison Pharma; Pierre Fabre; Pint Pharma; Puma Biotechnology; Specialised Therapeutics Asia
- Drug Class Antineoplastics; Nitriles; Pyridines; Quinolines; Small molecules
- Mechanism of Action Epidermal growth factor receptor antagonists; ERBB 2 receptor antagonists; ERBB 4 receptor antagonists; Protein tyrosine kinase inhibitors
- USA Patent Applicants PUMA BIOTECH
- USA Patents 14
- NDAs 1
- International Patents 187
- Patent Applications 1,099
Table of Contents

Disclaimer
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.